Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanom...

por Dono, M, Angelini, G, Cecconi, M, Amaro, A, Esposito, A I, Mirisola, V, Maric, I, Lanza, F, Nasciuti, F, Viaggi, S, Gualco, M, Bandelloni, R, Truini, M, Coviello, D A, Zupo, S, Mosci, C, Pfeffer, U
Publicado 2014

Subsequent hospitalisation experience of 5-year survivors of childhood, adolescent, and young adult cancer in Scotland: a population based, retrospective cohort study

por Brewster, D H, Clark, D, Hopkins, L, Bauer, J, Wild, S H, Edgar, A B, Wallace, W H
Publicado 2014

Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia

por Malesci, A, Basso, G, Bianchi, P, Fini, L, Grizzi, F, Celesti, G, Di Caro, G, Delconte, G, Dattola, F, Repici, A, Roncalli, M, Montorsi, M, Laghi, L
Publicado 2014

Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction

por Lee, G T, Kang, D I, Ha, Y-S, Jung, Y S, Chung, J, Min, K, Kim, T H, Moon, K H, Chung, J M, Lee, D H, Kim, W-J, Kim, I Y
Publicado 2014

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas

por Deb, S, Xu, H, Tuynman, J, George, J, Yan, Y, Li, J, Ward, R L, Mortensen, N, Hawkins, N J, McKay, M J, Ramsay, R G, Fox, S B
Publicado 2014

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study

por Uijterwaal, M H, Witte, B I, Van Kemenade, F J, Rijkaart, D, Ridder, R, Berkhof, J, Balfoort-van der Meij, G A M A, Bleeker, M C G, Snijders, P J F, Meijer, C J L M
Publicado 2014

Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells

por Hirata, H, Hinoda, Y, Shahryari, V, Deng, G, Tanaka, Y, Tabatabai, Z L, Dahiya, R
Publicado 2014

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity

por Gooden, M J M, Wiersma, V R, Boerma, A, Leffers, N, Boezen, H M, ten Hoor, K A, Hollema, H, Walenkamp, A M E, Daemen, T, Nijman, H W, Bremer, E
Publicado 2014

Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients

por Posch, C, Weihsengruber, F, Bartsch, K, Feichtenschlager, V, Sanlorenzo, M, Vujic, I, Monshi, B, Ortiz-Urda, S, Rappersberger, K
Publicado 2014

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate

por Khanim, F, Davies, N, Veliça, P, Hayden, R, Ride, J, Pararasa, C, Chong, M G, Gunther, U, Veerapen, N, Winn, P, Farmer, R, Trivier, E, Rigoreau, L, Drayson, M, Bunce, C
Publicado 2014

EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo

por Wei, J-H, Cao, J-Z, Zhang, D, Liao, B, Zhong, W-M, Lu, J, Zhao, H-W, Zhang, J-X, Tong, Z-T, Fan, S, Liang, C-Z, Liao, Y-B, Pang, J, Wu, R-H, Fang, Y, Chen, Z-H, Li, B, Xie, D, Chen, W, Luo, J-H
Publicado 2014

Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk

por Sovio, U, Li, J, Aitken, Z, Humphreys, K, Czene, K, Moss, S, Hall, P, McCormack, V, dos-Santos-Silva, I
Publicado 2014

A novel staging model to classify oesophageal squamous cell carcinoma patients in China

por Tan, H, Zhang, H, Xie, J, Chen, B, Wen, C, Guo, X, Zhao, Q, Wu, Z, Shen, J, Wu, J, Xu, X, Li, E, Xu, L, Wang, X
Publicado 2014

Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer

por Balgkouranidou, I, Chimonidou, M, Milaki, G, Tsarouxa, E G, Kakolyris, S, Welch, D R, Georgoulias, V, Lianidou, E S
Publicado 2014

Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer

por Xi, H Q, Cai, A Z, Wu, X S, Cui, J X, Shen, W S, Bian, S B, Wang, N, Li, J Y, Lu, C R, Song, Z, Wei, B, Chen, L
Publicado 2014

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c

por Nygren, M K, Tekle, C, Ingebrigtsen, V A, Mäkelä, R, Krohn, M, Aure, M R, Nunes-Xavier, C E, Perälä, M, Tramm, T, Alsner, J, Overgaard, J, Nesland, J M, Borgen, E, Børresen-Dale, A-L, Fodstad, Ø, Sahlberg, K K, Leivonen, S-K
Publicado 2014

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma

por Xue, Y, Wu, G, Liao, Y, Xiao, G, Ma, X, Zou, X, Zhang, G, Xiao, R, Wang, X, Liu, Q, Long, D, Yang, J, Xu, H, Liu, F, Liu, M, Xie, K, Huang, R
Publicado 2014

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours

por Eskens, F A L M, Tresca, P, Tosi, D, Van Doorn, L, Fontaine, H, Van der Gaast, A, Veyrat-Follet, C, Oprea, C, Hospitel, M, Dieras, V
Publicado 2014

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer

por Fornaro, L, Cereda, S, Aprile, G, Di Girolamo, S, Santini, D, Silvestris, N, Lonardi, S, Leone, F, Milella, M, Vivaldi, C, Belli, C, Bergamo, F, Lutrino, S E, Filippi, R, Russano, M, Vaccaro, V, Brunetti, A E, Rotella, V, Falcone, A, Barbera, M A, Corbelli, J, Fasola, G, Aglietta, M, Zagonel, V, Reni, M, Vasile, E, Brandi, G
Publicado 2014

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients

por Krenn-Pilko, S, Langsenlehner, U, Thurner, E-M, Stojakovic, T, Pichler, M, Gerger, A, Kapp, K S, Langsenlehner, T
Publicado 2014